Tower Research Capital LLC (Trc) Atreca, Inc. Transaction History

Tower Research Capital LLC (Trc)

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.13 - $0.38 $14 - $43	115 New	115 $0
Q2 2023 Aug 14, 2023	BUY	$0.88 - $1.22 $187 - $259	213 New	213 $0
Q4 2022 Feb 10, 2023	BUY	$0.78 - $1.68 $248 - $535	319 New	319 $0
Q2 2022 Aug 15, 2022	SELL	$1.56 - $3.25 $3,013 - $6,279	-1,932 Reduced 28.19%	4,921 $9,000
Q1 2022 May 12, 2022	SELL	$1.61 - $5.2 $22,295 - $72,009	-13,848 Reduced 66.9%	6,853 $22,000
Q4 2021 Feb 14, 2022	BUY	$2.87 - $6.29 $36,207 - $79,354	12,616 Added 156.04%	20,701 $63,000
Q3 2021 Nov 15, 2021	SELL	$4.91 - $9.07 $14,042 - $25,940	-2,860 Reduced 26.13%	8,085 $50,000
Q2 2021 Aug 16, 2021	BUY	$7.82 - $13.8 $72,686 - $128,271	9,295 Added 563.33%	10,945 $93,000
Q1 2021 May 17, 2021	SELL	$13.0 - $19.34 $25,207 - $37,500	-1,939 Reduced 54.03%	1,650 $25,000
Q4 2020 Feb 16, 2021	SELL	$13.03 - $17.09 $172,126 - $225,758	-13,210 Reduced 78.64%	3,589 $58,000
Q3 2020 Nov 16, 2020	BUY	$12.67 - $23.19 $165,343 - $302,629	13,050 Added 348.09%	16,799 $235,000
Q2 2020 Aug 13, 2020	BUY	$12.52 - $23.45 $46,937 - $87,914	3,749 New	3,749 $80,000
Q1 2020 May 15, 2020	SELL	$11.4 - $27.28 $36,981 - $88,496	-3,244 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$9.68 - $18.67 $30,782 - $59,370	3,180 Added 4968.75%	3,244 $50,000
Q3 2019 Nov 05, 2019	BUY	$10.42 - $22.04 $666 - $1,410	64 New	64 $1,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.